Overall Status

Completed (2)

Active, not recruiting (1)

Recruiting (1)

Phase

phase 1/phase 2 (1)

Sponsor

Bangkok Metropolitan Administration Medical College and Vajira Hospital (1)

Chang Gung Memorial Hospital (1)

Pfizer (1)

University of Bologna (1)

Intervention

bnt162b2 (1)

bnt162b2 (tozinameran) (1)

covid vaccine (1)

covid-19 vaccination (1)

mrna-1273 (1)

mvc-cov1901 (1)

Study Documents

Intervention Type

biological (4)

Funder Type

Other (3)

Industry (1)

Study Type

Observational (3)

Interventional (1)

breakthrough infection

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID-19, Breakthrough Infection Trial in Taoyuan city (BNT162b2, mRNA-1273, MVC-COV1901)

Active, not recruiting

COVID-19
Breakthrough Infection

BNT162b2
+2 more

Taoyuan city, Taiwan

Chang Gung Memorial Hospital

Jul 21, 2022

COVID-19 Vaccination and Breakthrough Infections Among Persons

Completed

Immunocompromised
+5 more

BNT162b2 (Tozinameran)

New York, New York

Pfizer Inc.

Jul 1, 2022

Monitoring COVID-19 Vaccination Response in Fragile Populations

Recruiting

SARS CoV 2 Infection
+2 more

COVID-19 vaccination

Buenos Aires, Argentina
+21 more

Feb 25, 2022

Antibody After COVID-19 Vaccination

Completed

Covid19
+4 more

COVID vaccine

Bangkok, Thailand

Faculty of Medicine,Vajira Hospital

Jan 10, 2022